...
Dryness & GSM faq

What are the best non-hormonal options for vaginal dryness?

The best non-hormonal options for vaginal dryness are regular vaginal moisturisers (used several times weekly) and a suitable personal lubricant for intimacy or examinations. Choose water-based (versatile, condom-friendly), silicone-based (long-lasting glide), or oil-based (rich feel but may degrade latex). Gentle vulval care and reducing irritants help. If symptoms persist, speak to a clinician about next steps such as local oestrogen or DHEA. Educational only. Results vary. Not a cure.

Clinical Context

Who may suit a non-hormonal plan? Anyone with mild-to-moderate GSM symptoms, those avoiding hormones (personal preference or medical reasons), and people seeking support while awaiting review. Hyaluronic-acid moisturisers can help hydration, but benefits depend on consistent use. If penetration is sharp or burning at the entrance with normal lubrication, pelvic floor over-activity or vestibulodynia may be the main driver—prioritise pelvic health physiotherapy and, if helpful, dilator work. If systemic HRT improves hot flushes but dryness persists, add local measures; GSM often needs local treatment even when systemic hormones are used.

Who should seek assessment first? People with new odour, clumpy or greenish discharge, ulcers or white plaques, visible blood in urine, or post-menopausal bleeding. Those with a history of hormone-sensitive cancer should discuss options (including non-hormonal regimens and, where appropriate, local oestrogen/DHEA) with oncology and menopause teams. Plan a 6–12-week follow-up after starting a moisturiser routine to review response and adjust to the lowest effective maintenance once comfortable.

Evidence-Based Approaches

The NHS provides clear, practical advice on symptoms and self-care for vaginal dryness and on when to seek help for painful sex (dyspareunia). The NICE Menopause Guideline (NG23) recommends offering information on vaginal moisturisers and lubricants and considering low-dose local vaginal oestrogen when symptoms affect quality of life, with or without systemic HRT. Prescribing details and cautions for UK products are set out in the British National Formulary (BNF).

Randomised trials synthesised by the Cochrane Library show that local oestrogens improve dryness, soreness, dyspareunia and vaginal pH versus placebo across formulations, with low systemic absorption at licensed doses—helpful context if non-hormonal care alone is insufficient. Peer-reviewed overviews indexed on PubMed discuss GSM terminology (atrophy/GSM), mechanisms (raised pH, lactobacilli loss), and the role of moisturisers (including hyaluronic acid), lubricants, vaginal DHEA and pelvic floor/psychosexual approaches.

Taken together, UK guidance supports a step-wise, patient-centred plan: start with non-hormonal foundations; escalate to local therapies when needed; and address pelvic floor, psychosexual, and lifestyle contributors to improve comfort and confidence.